Discussion in 'Situation Rooms' started by KittyKatSpanker, Mar 6, 2015.
This article was written in 2013. It mentions Reed Slatkin is "due to be released in May". Slatkin was released from prison in July 2013.
There was also this line: "McCamant said he believes the company will begin selling the drug in 2014."
Ibrutinib was approved by the US FDA on November 13, 2013 for the treatment of mantle cell lymphoma. On Feb. 12, 2014, the FDA expanded the approved use of ibrutinib to chronic lymphocytic leukemia (CLL). Further expansion to 17p deletion in CLL was approved 28 July 2014.
Choose a color via Color picker or click the predefined style names!